Cancer Clinical Investigation

Search results

• Anastrozole Combo Yields High Clinical Benefit in HR+/HER2+ Breast Cancer

  Tiersten, A.

  23/12/23

  1 item of Media coverage

  Press/Media

• Anastrozole Combo Yields High Clinical Benefit in HR+/HER2+ Breast Cancer

  Tiersten, A.

  23/12/23

  2 items of Media coverage

  Press/Media

• VIDEO: RuxoBEAT study probes ruxolitinib therapy in polycythemia vera

  Mascarenhas, J.

  22/12/23

  1 item of Media coverage

  Press/Media

• VIDEO: Ruxolitinib plus navitoclax yields ‘challenging’ results in myelofibrosis

  Mascarenhas, J.

  21/12/23

  1 item of Media coverage

  Press/Media

• VIDEO: Ruxolitinib plus pelabresib shows promise in MANIFEST-2 study

  Mascarenhas, J.

  21/12/23

  1 item of Media coverage

  Press/Media

• Researchers at Icahn School of Medicine at Mount Sinai Report New Data on Myelofibrosis (Manifest: Pelabresib In Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-naive Myelofibrosis)

  Hoffman, R., Kremyanskaya, M. & Mascarenhas, J.

  21/12/23

  1 item of Media coverage

  Press/Media

• Memorial Sloan-Kettering Cancer Center Researcher Yields New Findings on Multiple Myeloma (Bendamustine Bridging Versus Standard of Care Chemotherapy on Toxicity Profile for Multiple Myeloma Patients Undergoing CAR T Cell Therapy)

  Jagannath, S.

  20/12/23

  1 item of Media coverage

  Press/Media

• Reports Summarize Chronic Myelomonocytic Leukemia Research from Icahn School of Medicine at Mount Sinai (Impact of Facility Type on Survival in Chronic Myelomonocytic Leukemia: A Propensity Score Matched, National Cancer Database Analysis)

  Tremblay, D. & Mascarenhas, J.

  20/12/23

  1 item of Media coverage

  Press/Media

• Harvard Medical School Researcher Reports on Findings in Stem Cell Transplants (Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both ...)

  Levine, J.

  19/12/23

  1 item of Media coverage

  Press/Media

• New Myelodysplastic Syndromes Study Results Reported from Icahn School of Medicine at Mount Sinai (Phase 1b Trial of Irak 1/4 Inhibition for Low-Risk Myelodysplastic Syndrome Refractory/Resistant to Prior Therapies: A Trial in Progress)

  Silverman, L.

  18/12/23

  1 item of Media coverage

  Press/Media

• New Liver Cancer Study Findings Reported from Yangtze University (Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker)

  Wang, P.

  18/12/23

  1 item of Media coverage

  Press/Media

• Recent Research from Icahn School of Medicine at Mount Sinai Highlight Findings in Hematopoiesis (Clonal Hematopoiesis and Inflammation: a Review of Mechanisms and Clinical Implications)

  Marcellino, B. & Mascarenhas, J.

  18/12/23

  1 item of Media coverage

  Press/Media

• Researcher at Memorial Sloan-Kettering Cancer Center Discusses Research in Polycythemia Vera (Moving toward disease modification in polycythemia vera)

  Mascarenhas, J.

  18/12/23

  1 item of Media coverage

  Press/Media

• New Oropharyngeal Cancer Study Findings Have Been Reported by Investigators at Icahn School of Medicine at Mount Sinai (The Impact of Hospital Safety-net Burden Status On Patients With Hpv-positive Oropharyngeal Cancer)

  Kumar, A., Chai, R. & Roof, S.

  18/12/23

  1 item of Media coverage

  Press/Media

• Findings from University of Miami in the Area of Prostate Cancer Described (A Multi-institutional Study of 1,111 Men With 4k Score, Multiparametric Magnetic Resonance Imaging, and Prostate Biopsy)

  Tewari, A.

  18/12/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researcher Targets Chronic Myelomonocytic Leukemia (Phase 1/2 Study of Pacritinib in Combination with Azacitidine in Chronic Myelomonocytic Leukemia)

  Moshier, E., Tremblay, D., Mascarenhas, J. & Shih, A.

  18/12/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researcher Details New Studies and Findings in the Area of Multiple Myeloma (Confirmed Pathogenic Germline Variants in Cancer Predisposition Genes Incidentally Detected in Somatic Genomic Profiling of ...)

  Richter, J., Parekh, S., Laganà, A., Onel, K., Jagannath, S., Chari, A. & Rodriguez, C.

  18/12/23

  1 item of Media coverage

  Press/Media

• Oleg Gluz, MD, on Response to Endocrine Therapy: Findings From the ADAPTcycle Trial

  Tiersten, A.

  18/12/23

  1 item of Media coverage

  Press/Media

• The Cancer History Project’s top 25 stories of 2023

  Doroshow, D.

  15/12/23

  1 item of Media coverage

  Press/Media

• PET Response–Adapted Chemoradiotherapy for Esophageal and Esophagogastric Junction Adenocarcinoma

  Goodman, K.

  15/12/23

  1 item of Media coverage

  Press/Media

• Top 25 stories of 2023

  Doroshow, D.

  15/12/23

  1 item of Media coverage

  Press/Media

• Reports Summarize Myelodysplastic Syndromes Research from National Cancer Institute (NCI) (Donor Hematopoietic Cell Telomere Length and Magnitude of Post-HCT Shortening Predict Survival in Early Stage Leukemia and Myelodysplastic Syndrome)

  Levine, J.

  15/12/23

  1 item of Media coverage

  Press/Media

• Research on Myelofibrosis Reported by a Researcher at Icahn School of Medicine at Mount Sinai (Clinical Practice Gaps in Managing Patients with Myelofibrosis: Comparison of Healthcare Professional and Expert Treatment Choices Provided to an ...)

  Mascarenhas, J.

  14/12/23

  1 item of Media coverage

  Press/Media

• Research from Icahn School of Medicine at Mount Sinai Provides New Data on Thrombocytopenia (Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis)

  Srisuwananukorn, A., Tremblay, D. & Mascarenhas, J.

  14/12/23

  1 item of Media coverage

  Press/Media

• Geron Updates on 50% Enrollment in the Phase 3 IMpactMF Clinical Trial Evaluating Imetelstat in Patients with Relapsed/Refractory Myelofibrosis

  Mascarenhas, J.

  14/12/23

  1 item of Media coverage

  Press/Media